11 results
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Differential #Algorithm #Drugs ... #Malignancy #Exogenous ... #Hypoglycemic #Ddxof
Differential Diagnosis and Evaluation of Hyponatremia:
1) Identification of onset (acute vs. chronic)
2) Presence of symptoms (HA,
Differential Diagnosis ... and Evaluation ... renal disease), drug ... #EM #IM #Nephro ... Differential #Algorithm #Ddxof
Antinuclear Antibodies (ANA)
ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
likely it will be clinically ... • Pattern: The ANA ... often not specific ANA ... Non-Rheumatic Diseases: Malignancy ... #rheumatology #diagnosis
Ruptured AAA on POCUS

Nice pick up with a POCUS RUSH exam in a patient with undifferentiated
Ruptured AAA on ... to diagnose through ... sometimes - MCW EM ... #POCUS #clinical ... abdominal #aneurysm #aorta
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Workup: - ANA ... 40, F:M 9:1 • Clinical ... Workup: - ANA ... #rheumatology #diagnosis
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... findings (ANA, ... Differential Diagnosis ... Serositis Labs: • ANA ... antibodies • (-) ANA
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
association with CTD, drugs ... , malignancy and ... Organizing Pneumonia - Clinical ... • CTD workup: ANA ... pulmonary #ILD #diagnosis
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
Differential Diagnosis ... Approach (when evaluation ... Malignant or accelerated ... 109 mm Hg) with clinical ... Coarctation of aorta
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... tracheobronchial stenosis, malignancy ... Tuberculosis Diagnosis ... Acid-fast staining, NAA
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... tracheobronchial stenosis, malignancy ... Tuberculosis Diagnosis ... Acid-fast staining, NAA